Global Rabies Diagnostics Market to Reach $2.8 Billion by 2030
The global market for Rabies Diagnostics estimated at US$1.5 Billion in the year 2022, is projected to reach a revised size of US$2.8 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2022-2030. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is projected to record 7.5% CAGR and reach US$910.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Immunohistochemical Tests segment is readjusted to a revised 7.9% CAGR for the next 8-year period.The U.S. Market is Estimated at $416.8 Million, While China is Forecast to Grow at 11.2% CAGR
The Rabies Diagnostics market in the U.S. is estimated at US$416.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$602.3 Million by the year 2030 trailing a CAGR of 11.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 6.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.Select Competitors (Total 34 Featured) -
- Abbexa Ltd.
- Aviva Systems Biology Corporation
- BioNote, Inc.
- Bio-Rad Laboratories, Inc.
- Creative Diagnostics
- Demeditec Diagnostics GmbH
- Express Biotech International Inc.
- Merck KGaA
- MyBioSource.com
- Norgen Biotek Corp.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbexa Ltd.
- Aviva Systems Biology Corporation
- BioNote, Inc.
- Bio-Rad Laboratories, Inc.
- Creative Diagnostics
- Demeditec Diagnostics GmbH
- Express Biotech International Inc.
- Merck KGaA
- MyBioSource.com
- Norgen Biotek Corp.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 1.5 Billion |
Forecasted Market Value ( USD | $ 2.8 Billion |
Compound Annual Growth Rate | 8.1% |
Regions Covered | Global |